{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:43:12Z","timestamp":1767840192399,"version":"3.49.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1097\/inf.0000000000001180","type":"journal-article","created":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T17:20:47Z","timestamp":1461086447000},"page":"787-793","source":"Crossref","is-referenced-by-count":13,"title":["The Antibody Response Following a Booster With Either a 10- or 13-valent Pneumococcal Conjugate Vaccine in Toddlers Primed With a 13-valent Pneumococcal Conjugate Vaccine in Early Infancy"],"prefix":"10.1097","volume":"35","author":[{"given":"Johannes","family":"Tr\u00fcck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sena","family":"Jawad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Goldblatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Roalfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew D.","family":"Snape","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merryn","family":"Voysey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-18-20210202","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study.","volume":"11","author":"Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"R2-18-20210202","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"R3-18-20210202","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/infdis\/jiu213","article-title":"Reduction of invasive pneumococcal disease 3 years after the introduction of the 13-valent conjugate vaccine in the Oxfordshire region of England.","volume":"210","author":"Moore","year":"2014","journal-title":"J Infect Dis"},{"key":"R4-18-20210202","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1016\/j.vaccine.2015.04.005","article-title":"Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada.","volume":"33","author":"Deceuninck","year":"2015","journal-title":"Vaccine"},{"key":"R5-18-20210202","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0140-6736(12)61854-6","article-title":"Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial.","volume":"381","author":"Palmu","year":"2013","journal-title":"Lancet"},{"key":"R6-18-20210202","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.","volume":"15","author":"Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"R7-18-20210202","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1586\/14760584.2013.852475","article-title":"The history of pneumococcal conjugate vaccine development: dose selection.","volume":"12","author":"Poolman","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"R8-18-20210202","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1016\/j.vaccine.2010.06.026","article-title":"Glycoconjugate vaccines and immune interference: a review.","volume":"28","author":"Dagan","year":"2010","journal-title":"Vaccine"},{"key":"R9-18-20210202","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0140-6736(06)68304-9","article-title":"Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study.","volume":"367","author":"Prymula","year":"2006","journal-title":"Lancet"},{"key":"R10-18-20210202","doi-asserted-by":"crossref","first-page":"e1001657","DOI":"10.1371\/journal.pmed.1001657","article-title":"Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: a double-blind randomized controlled trial.","volume":"11","author":"Tregnaghi","year":"2014","journal-title":"PLoS Med"},{"key":"R11-18-20210202","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nm.2587","article-title":"A sweet T cell response.","volume":"17","author":"Rappuoli","year":"2011","journal-title":"Nat Med"},{"key":"R12-18-20210202","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1128\/CVI.00370-10","article-title":"Multilaboratory comparison of Streptococcus pneumoniae opsonophagocytic killing assays and their level of agreement for the determination of functional antibody activity in human reference sera.","volume":"18","author":"Rose","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"R14-18-20210202","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1016\/j.vaccine.2007.01.119","article-title":"Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies.","volume":"25","author":"Siber","year":"2007","journal-title":"Vaccine"},{"key":"R15-18-20210202","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1097\/INF.0b013e3181faa6be","article-title":"Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trial.","volume":"29","author":"Snape","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R16-18-20210202","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/cid\/cit428","article-title":"Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial.","volume":"57","author":"Dagan","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R17-18-20210202","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1473-3099(14)70822-9","article-title":"Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study.","volume":"14","author":"Andrews","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"R18-18-20210202","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.earlhumdev.2010.08.010","article-title":"Challenges in immunisation against bacterial infection in children.","volume":"86","author":"Tr\u00fcck","year":"2010","journal-title":"Early Hum Dev"},{"key":"R19-18-20210202","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/cid\/civ274","article-title":"Differential B-cell memory around the 11-month booster in children vaccinated with a 10- or 13-valent pneumococcal conjugate vaccine.","volume":"61","author":"van Westen","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R20-18-20210202","doi-asserted-by":"crossref","first-page":"e0144739","DOI":"10.1371\/journal.pone.0144739","article-title":"Direct comparison of immunogenicity induced by 10- or 13-valent pneumococcal conjugate vaccine around the 11-month booster in Dutch infants.","volume":"10","author":"Wijmenga-Monsuur","year":"2015","journal-title":"PLoS One"},{"key":"R21-18-20210202","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1073\/pnas.1201964109","article-title":"Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197.","volume":"109","author":"Malito","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R22-18-20210202","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/INF.0b013e318199f8ef","article-title":"Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.","volume":"28","author":"Vesikari","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R23-18-20210202","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1016\/j.vaccine.2010.02.087","article-title":"Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial.","volume":"28","author":"Russell","year":"2010","journal-title":"Vaccine"},{"key":"R24-18-20210202","doi-asserted-by":"crossref","first-page":"e91413","DOI":"10.1371\/journal.pone.0091413","article-title":"Pneumococcal serotype-specific antibodies persist through early childhood after infant immunization: follow-up from a randomized controlled trial.","volume":"9","author":"Tr\u00fcck","year":"2014","journal-title":"PLoS One"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000001180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:11:03Z","timestamp":1620954663000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201607000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001180","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}